BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 7695302)

  • 21. Randomized double-blinded trial of rifampin with either novobiocin or trimethoprim-sulfamethoxazole against methicillin-resistant Staphylococcus aureus colonization: prevention of antimicrobial resistance and effect of host factors on outcome.
    Walsh TJ; Standiford HC; Reboli AC; John JF; Mulligan ME; Ribner BS; Montgomerie JZ; Goetz MB; Mayhall CG; Rimland D
    Antimicrob Agents Chemother; 1993 Jun; 37(6):1334-42. PubMed ID: 8328783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eradication of carriage with methicillin-resistant Staphylococcus aureus: determinants of treatment failure.
    Ammerlaan HS; Kluytmans JA; Berkhout H; Buiting A; de Brauwer EI; van den Broek PJ; van Gelderen P; Leenders SA; Ott A; Richter C; Spanjaard L; Spijkerman IJ; van Tiel FH; Voorn GP; Wulf MW; van Zeijl J; Troelstra A; Bonten MJ;
    J Antimicrob Chemother; 2011 Oct; 66(10):2418-24. PubMed ID: 21719471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mupirocin for controlling methicillin-resistant Staphylococcus aureus: lessons from a decade of use at a university hospital.
    Vivoni AM; Santos KR; de-Oliveira MP; Giambiagi-deMarval M; Ferreira AL; Riley LW; Moreira BM
    Infect Control Hosp Epidemiol; 2005 Jul; 26(7):662-7. PubMed ID: 16092750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus: does mupirocin remain effective?
    Walker ES; Vasquez JE; Dula R; Bullock H; Sarubbi FA
    Infect Control Hosp Epidemiol; 2003 May; 24(5):342-6. PubMed ID: 12785407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term efficacy of mupirocin in the prevention of infections with meticillin-resistant Staphylococcus aureus in a gastroenterology unit.
    Dupeyron C; Campillo B; Richardet JP; Soussy CJ
    J Hosp Infect; 2006 Aug; 63(4):385-92. PubMed ID: 16772100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nasopharyngeal carriage, spa types and antibiotic susceptibility profiles of Staphylococcus aureus from healthy children less than 5 years in Eastern Uganda.
    Kateete DP; Asiimwe BB; Mayanja R; Mujuni B; Bwanga F; Najjuka CF; Källander K; Rutebemberwa E
    BMC Infect Dis; 2019 Dec; 19(1):1023. PubMed ID: 31791276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus with mupirocin during a hospital outbreak.
    Hill RL; Duckworth GJ; Casewell MW
    J Antimicrob Chemother; 1988 Sep; 22(3):377-84. PubMed ID: 3141347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy of intranasal mupirocin in the prevention of staphylococcal infections: a review of recent experience.
    Hudson IR
    J Hosp Infect; 1994 Jun; 27(2):81-98. PubMed ID: 7930545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo evaluations of the activities of lauric acid monoester formulations against Staphylococcus aureus.
    Rouse MS; Rotger M; Piper KE; Steckelberg JM; Scholz M; Andrews J; Patel R
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3187-91. PubMed ID: 16048923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methicillin-resistant Staphylococcus aureus (MRSA) nasal carriage among patients with diabetes at the Korle Bu Teaching Hospital.
    Anafo RB; Atiase Y; Kotey FCN; Dayie NTKD; Tetteh-Quarcoo PB; Duodu S; Osei MM; Alzahrani KJ; Donkor ES
    PLoS One; 2021; 16(9):e0257004. PubMed ID: 34534230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Highly effective regimen for decolonization of methicillin-resistant Staphylococcus aureus carriers.
    Buehlmann M; Frei R; Fenner L; Dangel M; Fluckiger U; Widmer AF
    Infect Control Hosp Epidemiol; 2008 Jun; 29(6):510-6. PubMed ID: 18510460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Two hospital staff with throat carriage of methicillin-resistant Staphylococcus aureus, which had to be treated with systemic antibiotics].
    van der Vorm ER; Groenendijk EH
    Ned Tijdschr Geneeskd; 2003 May; 147(22):1079-81. PubMed ID: 12814022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of chronic rhinosinusitis exacerbations due to methicillin-resistant Staphylococcus aureus with mupirocin irrigations.
    Solares CA; Batra PS; Hall GS; Citardi MJ
    Am J Otolaryngol; 2006; 27(3):161-5. PubMed ID: 16647979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intranasal mupirocin for outbreaks of methicillin-resistant Staphylococcus aureus.
    Bertino JS
    Am J Health Syst Pharm; 1997 Oct; 54(19):2185-91. PubMed ID: 9331438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus.
    Harbarth S; Liassine N; Dharan S; Herrault P; Auckenthaler R; Pittet D
    Clin Infect Dis; 2000 Dec; 31(6):1380-5. PubMed ID: 11096006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mupirocin resistance and methicillin-resistant Staphylococcus aureus (MRSA).
    Eltringham I
    J Hosp Infect; 1997 Jan; 35(1):1-8. PubMed ID: 9032630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-staphylococcal activity of indolmycin, a potential topical agent for control of staphylococcal infections.
    Hurdle JG; O'Neill AJ; Chopra I
    J Antimicrob Chemother; 2004 Aug; 54(2):549-52. PubMed ID: 15243028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals.
    Simor AE; Stuart TL; Louie L; Watt C; Ofner-Agostini M; Gravel D; Mulvey M; Loeb M; McGeer A; Bryce E; Matlow A;
    Antimicrob Agents Chemother; 2007 Nov; 51(11):3880-6. PubMed ID: 17724154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antibiotic ointments and methicillin-resistant Staphylococcus aureus with a reservoir in a healthcare worker in a tertiary hospital].
    Molina-Cabrillana J; Del Rosario-Quintana C; Tosco-Núñez T; Dorta-Hung E; Quori A; Martín-Sánchez AM
    Enferm Infecc Microbiol Clin; 2013 Oct; 31(8):511-5. PubMed ID: 23218870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity and resistance rates of topical antimicrobials fusidic acid, mupirocin and ozenoxacin against skin and soft tissue infection pathogens obtained across Canada (CANWARD 2007-18).
    Zhanel GG; Adam HJ; Baxter M; Lagace-Wiens PRS; Karlowsky JA
    J Antimicrob Chemother; 2021 Jun; 76(7):1808-1814. PubMed ID: 33792700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.